Stratec SE (ETR:SBS – Get Free Report)’s stock price rose 0.4% on Friday . The company traded as high as €24.80 and last traded at €24.60. Approximately 2,128 shares traded hands during trading, a decline of 66% from the average daily volume of 6,253 shares. The stock had previously closed at €24.50.
Stratec Price Performance
The company has a debt-to-equity ratio of 48.53, a quick ratio of 1.65 and a current ratio of 4.23. The company has a market capitalization of $295.54 million, a PE ratio of 29.52, a P/E/G ratio of 10.43 and a beta of 0.81. The company’s 50-day simple moving average is €20.41 and its 200-day simple moving average is €19.04.
Stratec Company Profile
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.
Featured Stories
- Five stocks we like better than Stratec
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.
